Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
GAB Robins was a prominent global provider of risk management, loss adjusting, and claims management services, with a specialized focus on the insurance industry. While not a drug developer, the company maintained a significant presence in the healthcare and life sciences sectors through its Managed Care division and its Life Sciences practice group. These units provided medical case management, workers' compensation administration, and specialized liability handling for pharmaceutical, biotechnology, and medical device companies. The company's North American operations were acquired by Cunningham Lindsey in 2014, and its various international divisions have since been integrated into larger entities such as Sedgwick. Its primary value proposition was the technical expertise required to manage complex clinical and professional indemnity claims.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on GAB Robins.